One child's care for a rare brain tumor, including proton radiation
Original title: FOXR2-Mediated CNS Neuroblastoma in a Pediatric Patient Treated With Multimodal Therapy Including Proton Craniospinal Irradiation: A Case Report.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
This is one child's story using treatments doctors already give, not a study that proves they work.
The short version
Doctors describe how they treated a four-year-old girl with a rare and aggressive brain tumor.
What was studied. This is a report about one patient, a four-year-old girl. She had a rare tumor called FOXR2-altered CNS neuroblastoma, and it was in more than one spot.
What they found. Her doctors used several treatments together. Surgeons removed part of the tumor, and she was given a set chemotherapy plan called ACNS0334. She also had a transplant using her own stem cells, plus proton radiation to the brain and spine with an extra dose to one area. The report explains the thinking behind these choices. It does not report how she is doing now.
What this means, and what it doesn't
What it could mean: The treatments described here are ones doctors already use. The doctors chose proton radiation because it may cause less long term harm in very young children. If your child has this rare tumor, this is the kind of plan a specialist team may talk with you about.
What it doesn't mean: This is a report about one single child. It is not a study, and it does not compare treatments or prove that one works better than another. One patient's story cannot tell us how other children will do. Nothing here is a promise of a cure.
Source: PubMed, June 15, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.